Muhammad Anwar, MD
Anesthesiology · Guilford, CTNPI 1730164922
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 24.9% of the total. Among anesthesiology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$959
- AbbVie$833
- Johnson & Johnson$427
- QOL Medical, LLC$413
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$285
- Intercept Pharmaceuticals, Inc.$179
- plus $757 from 14 others
What the payments were for
- Consulting fees$130%
- Food & beverage$3,841100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 56 | $959 |
| AbbVie | 48 | $833 |
| Johnson & Johnson | 20 | $427 |
| QOL Medical, LLC | 27 | $413 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $285 |
| Intercept Pharmaceuticals, Inc. | 10 | $179 |
| Ardelyx, Inc. | 7 | $141 |
| Bristol Myers Squibb | 7 | $129 |
| Aimmune Therapeutics, Inc. | 4 | $118 |
| Lilly USA, LLC | 5 | $87 |
| Regeneron Healthcare Solutions, Inc. | 4 | $76 |
| Ferring Pharmaceuticals Inc. | 3 | $53 |
| Redhill Biopharma Inc. | 1 | $25 |
| Mirum Pharmaceuticals, Inc. | 1 | $22 |
| Sanofi | 1 | $22 |
| Fresenius Kabi USA, LLC | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Vivus LLC | 1 | $14 |
How this compares
$3,853 in reported general payments places this provider in the 95th percentile of 664 anesthesiology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Guilford
- Christopher SpencerGuilford$3K
- Zeev KainNew Haven$273K
- Alison ConsidineNew Haven$82K
- Sanjay SinhaHartford$42K
- William RosenblattNew Haven$40K
- Paul HeerdtNew Haven$36K
- Antonio PazBrookfield$27K
- Honghui FengOld Saybrook$20K
- Prakash PatelNew Haven$20K
- Aymen AlianNew Haven$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.